BridgeBio Pharma Presents Additional Clinical Outcomes Data

- As previously announced, the primary endpoint (a hierarchical analysis inclusive of all-cause mortality and frequency of cardiovascular-related...

Related Keywords

United States ,Ukraine ,American ,Vikram Bali ,Securities Exchange ,University Of South Carolina ,Steering Committee ,European Society Of Cardiology Congress ,Twitter ,Bridgebio Pharma Inc ,Linkedin ,Bio Pharma Inc ,Nasdaq ,Drug Administration ,Exchange Commission ,American Heart Association ,Win Ratio ,Hazard Ratio ,New Drug Application ,Bio Pharma ,Scientific Sessions ,European Society ,Cardiology Congress ,Daniel Judge ,Medical University ,South Carolina ,Bridgebio Pharma ,Securities Act ,Securities Exchange Act ,Exchange Act ,Risk Factors ,Annual Report ,Bio Media Contact ,Nasdaq Bbio ,Nc ,